Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
基于法国指定ATU数据的真实世界研究：贝兰他单抗（GSK2857916）治疗复发或难治性多发性骨髓瘤的疗效和安全性研究：IFM 2020-04研究
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2022.281772
Talbot, Alexis; Bobin, Arthur; Tabone, Léa; Lambert, Jérôme; Boccaccio, Catherine; Deal, Cécile; Petillon, Marie-Odile; Allangba, Olivier; Agape, Philippe; Arnautou, Pierre; Belkhir, Rakiba; Cailleres, Sylvie; Chaoui, Driss; Chrétien, Marie-Lorraine; Decaux, Olivier; Schulmann, Samantha; Frenzel, Laurent; Gastaud, Lauris; Huart, Antoine; Hulin, Cyrille; Karlin, Lionel; Laribi, Kamel; Le Calloch, Ronan; Lenain, Pascal; Macro, Margaret; Manier, Salomon; Montes, Lydia; Moreau, Stéphane; Moreau, Philippe; Morel, Véronique; Norwood, James; Piocelle, Frédérique Orsini; Perrot, Aurore; Pica, Gian Matteo; Rey, Philippe; Schmitt, Anna; Stoppa, Anne-Marie; Tiab, Mourad; Touzeau, Cyrille; Vidal, Valérie; Vignon, Marguerite; Vincent, Laure; Van De Wyngaert, Zoé; Zarnitsky, Charles; Kerbouche, Naima; Paka, Prani; Leleu, Xavier; Arnulf, Bertrand; Avet-Loiseau, Hervé; Du Myélome, Ifm Intergroupe Francophone
